FundedIQ
Biotechnology

Wenzel Spine: Funding, Investors & Team (Sep 2026)

Wenzel Spine, Inc. is a medical technology company focused on providing innovative diagnostic and minimally invasive surgical solutions for the treatment of spinal disorders. The company focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time.

www.wenzelspine.com LinkedIn Austin, United States 11-50 employees
Health Care Health Diagnostics Life Science Medical Medical Device
Total raised
$500k
Rounds
1
Latest
Undisclosed round
Nov 2021

Wenzel Spine has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in Nov 2021.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Wenzel Spine Company Profile and Key Stats

Total funding raised
$500k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$500k in Nov 2021
Employees
11-50
reported band
Headquarters
Austin, United States

Latest funding round on record: Nov 2021.

Wenzel Spine Funding Rounds

Date
Round
Amount
Undisclosed round
$500k

Wenzel Spine Founders and Leadership Team

Name
Role
Contact
Chad Neely
CEO
Locked

Contact details for the Wenzel Spine team: 1 of 1 has an email address on file.

Start 14-day free trial →

Wenzel Spine Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Wenzel Spine's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Wenzel Spine in Biotechnology and Austin

Companies Similar to Wenzel Spine

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Wenzel Spine Funding FAQs

What does Wenzel Spine do?

Wenzel Spine, Inc. is a medical technology company focused on providing innovative diagnostic and minimally invasive surgical solutions for the treatment of spinal disorders. The company focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time.

How much funding has Wenzel Spine raised?

Wenzel Spine has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in Nov 2021.

When did Wenzel Spine last raise funding?

Wenzel Spine's most recent funding round on record is an undisclosed round of $500k, announced in Nov 2021.

Who is the CEO of Wenzel Spine?

Chad Neely is listed as CEO at Wenzel Spine.

Where is Wenzel Spine headquartered?

Wenzel Spine is based in Austin, Texas, United States.

How many employees does Wenzel Spine have?

Wenzel Spine is in the 11-50 employee band.

How does Wenzel Spine's funding compare to other Biotechnology startups?

Wenzel Spine's latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Wenzel Spine Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Wenzel Spine is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.